Counselors in Provincetown, MA Accepting Medicare

4 Counselors found. Showing 1 - 4

Harvey Taylor Wilson, LICSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 21 Bayberry Ave, Provincetown, MA 02657 Phone: 508-487-2735

Chelsea Crowe, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 74 Atkins Mayo Rd, Provincetown, MA 02657 Phone: 551-404-4180

Jennifer Louise Shannon, MSW, LICSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 30 Conwell St, #1, Provincetown, MA 02657 Phone: 508-487-1192    Fax: 508-487-5813

Michael Dubour, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 26 Nelson Ave, Provincetown, MA 02657 Phone: 917-359-7373

News Archive

Chocolate can lower blood pressure and reduce risk of heart disease: Study

Easter eggs and other chocolate may be good for you - at least in small quantities and preferably if it's dark chocolate - according to research that shows just one small square of chocolate a day can lower your blood pressure and reduce your risk of heart disease. The study is published online today (Wednesday 31 March) in the European Heart Journal.

Allen Institute for Cell Science releases gene edited, fluorescently tagged human iPS cells

The Allen Institute for Cell Science has released the Allen Cell Collection: the first publicly available collection of gene edited, fluorescently tagged human induced pluripotent stem cells that target key cellular structures with unprecedented clarity.

Researchers confirm safety of cancer-specific PET probe in first-in-human clinical studies

A group of researchers led by Assistant Professor WATABE Tadashi of the Graduate School of Medicine of Osaka University achieved the stable domestic production of automatic synthesis modules for positron emission tomography (PET) probe F-18 NKO-035, a LAT1-selective amino acid derivative radiolabeled with 18F, confirming its safety in first-in-human clinical studies conducted at Osaka University Hospital in November 2019.

FDA approves RYTARY for Parkinson's disease treatment

Impax Pharmaceuticals, a division of Impax Laboratories, Inc., today announced that the U.S. Food and Drug Administration approved RYTARY, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication and / or manganese intoxication.

Read more Medical News

› Verified 5 days ago